Geneos Wealth Management Inc. Purchases 1,092 Shares of Oracle Co. (NYSE:ORCL)

Geneos Wealth Management Inc. lifted its position in Oracle Co. (NYSE:ORCLFree Report) by 6.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 18,828 shares of the enterprise software provider’s stock after buying an additional 1,092 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Oracle were worth $2,365,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in ORCL. Westend Capital Management LLC acquired a new stake in Oracle in the 1st quarter worth approximately $25,000. Orion Capital Management LLC acquired a new position in shares of Oracle during the third quarter worth approximately $25,000. Spartan Planning & Wealth Management acquired a new position in shares of Oracle during the third quarter worth approximately $27,000. Tidemark LLC acquired a new position in shares of Oracle during the fourth quarter worth approximately $29,000. Finally, Frank Rimerman Advisors LLC acquired a new position in shares of Oracle during the fourth quarter worth approximately $30,000. Institutional investors own 42.44% of the company’s stock.

Oracle Stock Up 0.5 %

ORCL stock traded up $0.69 during mid-day trading on Thursday, reaching $142.76. The company had a trading volume of 5,235,406 shares, compared to its average volume of 8,618,752. The company has a debt-to-equity ratio of 8.25, a current ratio of 0.71 and a quick ratio of 0.72. The stock has a 50 day simple moving average of $129.75 and a two-hundred day simple moving average of $120.27. The company has a market capitalization of $393.43 billion, a price-to-earnings ratio of 38.52, a PEG ratio of 2.63 and a beta of 1.02. Oracle Co. has a 52 week low of $99.26 and a 52 week high of $145.79.

Oracle (NYSE:ORCLGet Free Report) last issued its earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 EPS for the quarter, missing the consensus estimate of $1.65 by ($0.02). Oracle had a return on equity of 223.01% and a net margin of 19.76%. The business had revenue of $14.29 billion for the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter in the prior year, the firm posted $1.35 earnings per share. The business’s revenue was up 3.3% compared to the same quarter last year. As a group, equities analysts predict that Oracle Co. will post 5.01 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 25th. Stockholders of record on Thursday, July 11th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, July 11th. This represents a $1.60 annualized dividend and a dividend yield of 1.12%. Oracle’s dividend payout ratio is currently 43.13%.

Insider Transactions at Oracle

In related news, Director George H. Conrades sold 20,000 shares of Oracle stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $116.00, for a total transaction of $2,320,000.00. Following the completion of the sale, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,068,976. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Oracle news, Director George H. Conrades sold 25,000 shares of Oracle stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $116.13, for a total value of $2,903,250.00. Following the completion of the transaction, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,071,294.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director George H. Conrades sold 20,000 shares of the business’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $116.00, for a total value of $2,320,000.00. Following the transaction, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,068,976. The disclosure for this sale can be found here. In the last three months, insiders sold 385,639 shares of company stock worth $53,002,729. 42.80% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

ORCL has been the subject of a number of research analyst reports. Sanford C. Bernstein upped their price target on Oracle from $159.00 to $171.00 and gave the stock an “outperform” rating in a report on Wednesday, June 12th. HSBC upped their price target on Oracle from $144.00 to $155.00 and gave the stock a “buy” rating in a report on Wednesday, March 13th. JMP Securities restated a “market perform” rating on shares of Oracle in a research note on Tuesday, June 11th. Deutsche Bank Aktiengesellschaft upped their target price on Oracle from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, June 17th. Finally, The Goldman Sachs Group upped their target price on Oracle from $115.00 to $130.00 and gave the company a “neutral” rating in a research note on Wednesday, March 13th. Fourteen research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $145.83.

Get Our Latest Stock Analysis on Oracle

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Read More

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.